The author deals with the issue of influenza and its vaccination from the point of view of the physician reviewer. Former confusions related to the way of refunding of the vaccine and its delayed supplies made difficulties to physicians and patients in autumn 2006. At the end of the article, the treatment by virostatics and their refunding by health insurance companies are described briefly

        Key words: vaccination against influenza – types of vaccines – indication limitation of refunding – ways of refunding – – clients of institutionalized institutes – antivirotics – conditions for refunding Oseltamivire and Zanamivire